|Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies|
RE Chen, X Zhang, JB Case, ES Winkler, Y Liu, LA VanBlargan, J Liu, ...
Nature medicine 27 (4), 717-726, 2021
|Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm|
PA Mudd, JC Crawford, JS Turner, A Souquette, D Reynolds, D Bender, ...
Science advances 6 (50), eabe3024, 2020
|SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans|
JS Turner, W Kim, E Kalaidina, CW Goss, AM Rauseo, AJ Schmitz, ...
Nature, 1-5, 2021
|Increased platelet reactivity in HIV-1–infected patients receiving abacavir-containing antiretroviral therapy|
CS Satchell, JA O’Halloran, AG Cotter, AJ Peace, EF O’Connor, ...
Journal of Infectious Diseases 204 (8), 1202-1210, 2011
|The effect of initiation of antiretroviral therapy on monocyte, endothelial and platelet function in HIV‐1 infection|
JA O'Halloran, E Dunne, MMP Gurwith, JS Lambert, GJ Sheehan, ...
HIV medicine 16 (10), 608-619, 2015
|Effect of Immunosuppression on the immunogenicity of mRNA vaccines to SARS-CoV-2: a prospective cohort study|
P Deepak, W Kim, MA Paley, M Yang, AB Carvidi, EG Demissie, ...
Annals of Internal Medicine, 2021
|SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses|
JS Turner, JA O’Halloran, E Kalaidina, W Kim, AJ Schmitz, JQ Zhou, T Lei, ...
Nature 596 (7870), 109-113, 2021
|The expression of cholesterol metabolism genes in monocytes from HIV-infected subjects suggests intracellular cholesterol accumulation|
ER Feeney, N McAuley, JA O'Halloran, C Rock, J Low, CS Satchell, ...
The Journal of infectious diseases 207 (4), 628-637, 2013
|Cryptococcosis today: It is not all about HIV infection|
JA O’Halloran, WG Powderly, A Spec
Current clinical microbiology reports 4 (2), 88-95, 2017
|Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19|
D Scozzi, M Cano, L Ma, D Zhou, JH Zhu, JA O’Halloran, C Goss, ...
JCI insight 6 (4), 2021
|Effect of infectious disease consultation on mortality and treatment of patients with candida bloodstream infections: a retrospective, cohort study|
C Mejia-Chew, JA O'Halloran, MA Olsen, D Stwalley, R Kronen, C Lin, ...
The Lancet Infectious Diseases 19 (12), 1336-1344, 2019
|Pitfalls associated with the use of molecular diagnostic panels in the diagnosis of cryptococcal meningitis|
JA O’Halloran, A Franklin, W Lainhart, CA Burnham, W Powderly, ...
Open forum infectious diseases 4 (4), ofx242, 2017
|Hepatitis B virus vaccine failure resulting in chronic hepatitis B infection|
JA O’halloran, CF De Gascun, L Dunford, MJ Carr, J Connell, R Howard, ...
Journal of clinical virology 52 (2), 151-154, 2011
|Understanding mechanisms to promote successful aging in persons living with HIV|
GV Escota, JA O’Halloran, WG Powderly, RM Presti
International Journal of Infectious Diseases 66, 56-64, 2018
|Switching from abacavir to tenofovir disoproxil fumarate is associated with rises in soluble glycoprotein VI, suggesting changes in platelet–collagen interactions|
JA O’Halloran, E Dunne, W Tinago, S Denieffe, D Kenny, PWG Mallon
Aids 32 (7), 861-866, 2018
|Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection|
L Ma, SK Sahu, M Cano, V Kuppuswamy, J Bajwa, JN McPhatter, A Pine, ...
Science Immunology 6 (59), eabh2259, 2021
|CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14|
BK Patterson, H Seethamraju, K Dhody, MJ Corley, K Kazempour, ...
International Journal of Infectious Diseases 103, 25-32, 2021
|High-density lipoprotein levels and 10-year cardiovascular risk in HIV-1-infected patients|
AG Cotter, CS Satchell, JA O'halloran, ER Feeney, CA Sabin, ...
Aids 25 (6), 867-869, 2011
|The HIV Care Cascade and sub-analysis of those linked to but not retained in care: the experience from a tertiary HIV referral service in Dublin Ireland|
P McGettrick, B Ghavami-Kia, W Tinago, A Macken, J O’Halloran, ...
HIV clinical trials 18 (3), 93-99, 2017
|Documented prevalence of HIV type 1 antiretroviral transmitted drug resistance in Ireland from 2004 to 2008|
CF De Gascun, A Waters, C Regan, J O'Halloran, G Farrell, S Coughlan, ...
AIDS research and human retroviruses 28 (3), 276-281, 2012